Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Total-Stockholder-Equity" stands at 45.78 Billion Hong Kong Dollars as of 06/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Total Stockholder Equity" stands at 45.78 Billion HKD. This represents no change compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 16.74 percent compared to the value the year prior.
The 1 year change in percent is 16.74.
The 3 year change in percent is 18.15.
The 5 year change in percent is 10.30.
The 10 year change in percent is 513.90.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Stockholder Equity | 280,205,508,085.11 |